TY - JOUR
T1 - Multiplexed sensing techniques for cardiovascular disease biomarkers - A review
AU - Mani, Veerappan
AU - Durmus, Ceren
AU - Khushaim, Walaa
AU - Ferreira, Daísy Camargo
AU - Timur, Suna
AU - Arduini, Fabiana
AU - Salama, Khaled Nabil
N1 - Funding Information:
This work was supported financially by King Abdullah University of Science and Technology ( KAUST ), Saudi Arabia. In addition, we acknowledge the funding from the KAUST smart health initiative.
Publisher Copyright:
© 2022 Elsevier B.V.
PY - 2022/11/15
Y1 - 2022/11/15
N2 - Cardiovascular diseases (CVDs) are the number one cause of death worldwide, taking 17.9 million lives each year. The rapid, sensitive, and accurate determination of cardiac biomarkers is vital for the timely diagnosis of CVDs. For accurate diagnosis, dependence on a single biomarker is unreliable because each one has also been linked to other diseases. To overcome this problem, the multiplexed determination of two or more markers has emerged as a promising alternative to single-marker analysis. Over the last 5 years, research interest in the development of biosensors for targeting multiple cardiac markers has increased. In this study, we critically reviewed the various multiplexed biosensing approaches reported during the last 5 years, categorizing them by signal readouts. Prospective detection configurations, capture probes, electrode design strategies, electrode types, nanomaterials, reporter tags, and assay types were reviewed, tabulated, and critically discussed. Then, their advantages and limitations were highlighted. For each category, we provided our perspective as well as the overall critical discussion. Lastly, we summarized potential commercial multiplexed cardiac biosensors and commented on the challenges and future prospects for such sensors.
AB - Cardiovascular diseases (CVDs) are the number one cause of death worldwide, taking 17.9 million lives each year. The rapid, sensitive, and accurate determination of cardiac biomarkers is vital for the timely diagnosis of CVDs. For accurate diagnosis, dependence on a single biomarker is unreliable because each one has also been linked to other diseases. To overcome this problem, the multiplexed determination of two or more markers has emerged as a promising alternative to single-marker analysis. Over the last 5 years, research interest in the development of biosensors for targeting multiple cardiac markers has increased. In this study, we critically reviewed the various multiplexed biosensing approaches reported during the last 5 years, categorizing them by signal readouts. Prospective detection configurations, capture probes, electrode design strategies, electrode types, nanomaterials, reporter tags, and assay types were reviewed, tabulated, and critically discussed. Then, their advantages and limitations were highlighted. For each category, we provided our perspective as well as the overall critical discussion. Lastly, we summarized potential commercial multiplexed cardiac biosensors and commented on the challenges and future prospects for such sensors.
KW - Cardiac troponin
KW - Cardiovascular disease
KW - Immunoassay
KW - Multiple biomarker panel
KW - Multiplexed
KW - Myocardial infarction
KW - Simultaneous detection
UR - http://www.scopus.com/inward/record.url?scp=85138120201&partnerID=8YFLogxK
U2 - 10.1016/j.bios.2022.114680
DO - 10.1016/j.bios.2022.114680
M3 - Article
C2 - 36113389
AN - SCOPUS:85138120201
SN - 0956-5663
VL - 216
JO - Biosensors and Bioelectronics
JF - Biosensors and Bioelectronics
M1 - 114680
ER -